search
Back to results

Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.

Primary Purpose

Hyperlipidemia, Dyslipidemia

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Minute Maid Heart Wise orange juice
Welchol
Sponsored by
University of Colorado, Denver
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hyperlipidemia focused on measuring Antilipemic agents, hyperlipidemia

Eligibility Criteria

18 Years - 89 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Diagnosis of high cholesterol being treated with a statin LDL cholesterol greater than 100 Ability to swallow large tablets Exclusion Criteria: Diabetes Use of other medications to treat high cholesterol History of liver disease

Sites / Locations

  • University of Colorado at Denver and Health Sciences Center

Outcomes

Primary Outcome Measures

LDL cholesterol

Secondary Outcome Measures

Triglycerides, HDL cholesterol, total cholesterol, C-reactive protein, Apolipoprotein B

Full Information

First Posted
November 3, 2005
Last Updated
March 24, 2017
Sponsor
University of Colorado, Denver
Collaborators
Daiichi Sankyo, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00249938
Brief Title
Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.
Official Title
Evaluation of Plant Sterol and Placebo on Low-density Lipoprotein Concentrations in Hyperlipidemic Patients Treated With Combination Statin and Colesevelam Therapy.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
March 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
August 2006 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Colorado, Denver
Collaborators
Daiichi Sankyo, Inc.

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to see if combination therapy with a "statin" medication and two additional agents that work differently than "statin" medications can further lower the so-called "bad cholesterol." One therapy is a prescription drug approved by the Food and Drug Administration to treat high cholesterol (Welchol). The other therapy is Minute Maid Heart Wise orange juice. This study juice is available in supermarkets and contains plant sterols that have been shown to lower cholesterol.
Detailed Description
Coronary heart disease (CHD) is the primary cause of morbidity and mortality in the United States. Lowering LDL cholesterol in both patients with and without CHD reduces coronary events and death. Statin medications are the primary mechanism of lowering LDL cholesterol, but some patients do not reach their goal LDL with maximum tolerated statin doses and must utilize combination therapy to further lower cholesterol. Additionally, some patients prefer to utilize "natural" mechanisms to lower cholesterol. This prospective, double-blinded, randomized study will compare plant sterol (natural cholesterol treatment) with placebo in patients treated with combination statin and colesevelam therapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperlipidemia, Dyslipidemia
Keywords
Antilipemic agents, hyperlipidemia

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
60 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Minute Maid Heart Wise orange juice
Intervention Type
Drug
Intervention Name(s)
Welchol
Primary Outcome Measure Information:
Title
LDL cholesterol
Secondary Outcome Measure Information:
Title
Triglycerides, HDL cholesterol, total cholesterol, C-reactive protein, Apolipoprotein B

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of high cholesterol being treated with a statin LDL cholesterol greater than 100 Ability to swallow large tablets Exclusion Criteria: Diabetes Use of other medications to treat high cholesterol History of liver disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sunny Linnebur, Pharm.D.
Organizational Affiliation
University of Colorado, Denver
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Colorado at Denver and Health Sciences Center
City
Denver
State/Province
Colorado
ZIP/Postal Code
80262
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.

We'll reach out to this number within 24 hrs